AGC Biologics vs Charles River Laboratories: CDMO Comparison
How does AGC Biologics compare to Charles River Laboratories?
As of Oct 2026, AGC Biologics: 4 FDA inspections (including 1 NAI, 3 VAI and 0 OAI), 27 EMA/MHRA GMP certificates. Signal Score 79.9. Charles River Laboratories: 9 FDA inspections (including 6 NAI, 3 VAI and 0 OAI), 11 EMA/MHRA GMP certificates. Signal Score 86.3. Counts are the established FDA, EMA and MHRA records on each profile. CDMOs cannot pay to change a score.
Side-by-side comparison of AGC Biologics and Charles River Laboratories on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Charles River Laboratories has more FDA inspections on record (9 vs 4) — a deeper regulatory paper trail.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- AGC Biologics has materially broader EMA GMP coverage (27 active certificates vs 9) — stronger EU footprint.
- Charles River Laboratories maintains 2 MHRA / UK GMP certificates; AGC Biologics does not.
Across the cross-modality scorecard, Charles River Laboratories carries the higher composite Signal Score — but the right choice depends on the specific modality, phase, and geography of the program.
Frequently asked: AGC Biologics vs Charles River Laboratories
How does AGC Biologics compare to Charles River Laboratories?
On CDMO Signal's composite Signal Score, AGC Biologics is 80/100 and Charles River Laboratories is 86/100; AGC Biologics has 4 FDA inspections on record vs 9 for Charles River Laboratories; European coverage is 27 active EMA+MHRA certificates for AGC Biologics vs 11 for Charles River Laboratories. Both are tracked in the CDMO Signal directory. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which has the stronger FDA inspection record, AGC Biologics or Charles River Laboratories?
Both AGC Biologics and Charles River Laboratories maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. AGC Biologics has 4 FDA inspections on record; Charles River Laboratories has 9.
How do AGC Biologics and Charles River Laboratories compare on European GMP coverage?
AGC Biologics holds 27 active EMA GMP certificates and 0 MHRA / UK certificates. Charles River Laboratories holds 9 active EMA GMP certificates and 2 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is more active in clinical-stage manufacturing — AGC Biologics or Charles River Laboratories?
AGC Biologics is matched to 2 ClinicalTrials.gov records as a manufacturing partner; Charles River Laboratories is matched to 0. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.
What does the Signal Score gap mean in practice?
AGC Biologics carries a Signal Score of 80/100 and Charles River Laboratories carries 86/100 — a small lead for Charles River Laboratories. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →